Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Daiichi Sankyo
Mallinckrodt
Queensland Health
Teva
McKesson
Fuji
US Army
Express Scripts

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200327

« Back to Dashboard

NDA 200327 describes TEFLARO, which is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TEFLARO profile page.

The generic ingredient in TEFLARO is ceftaroline fosamil. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ceftaroline fosamil profile page.
Summary for 200327
Tradename:TEFLARO
Applicant:Allergan Sales Llc
Ingredient:ceftaroline fosamil
Patents:5
Pharmacology for NDA: 200327
Ingredient-typeCephalosporins
Suppliers and Packaging for NDA: 200327
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327 NDA Allergan, Inc. 0456-0400 N 0456-0400-10
TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327 NDA Allergan, Inc. 0456-0600 N 0456-0600-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION)Strength400MG/VIAL
Approval Date:Oct 29, 2010TE:RLD:Yes
Regulatory Exclusivity Expiration:May 27, 2019
Regulatory Exclusivity Use:NEW PATIENT POPULATION
Patent:➤ Try a Free TrialPatent Expiration:Apr 11, 2022Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHODS FOR TREATING BACTERIAL INFECTIONS
Patent:➤ Try a Free TrialPatent Expiration:Dec 15, 2021Product Flag?YSubstance Flag?YDelist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Johnson and Johnson
Covington
Moodys
Harvard Business School
Argus Health
Federal Trade Commission
McKinsey
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.